Gingival Recession, LocalizedNCT04165044
L-PRF Versus Connective Tissue Graft Associated to Coronally Advanced Flap in Gingival Recession Treatment
A study testing Leukocyte and Platelet Rich Fibrin plus Coronally Advanced Flap and Connective tissue graft plus Coronally Advanced Flap in people with Gingival Recession, Localized, run by Universidad de los Andes, Chile at 1 site in Chile.
Trial summary
Background: Nowadays, the use of connective tissue graft associated to the coronally advanced flap is considered the "gold standard" for localized gingival recession treatment. However, this technique requires a donor site, which can be associated with greater morbidity. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Gingival Recession, Localized
- What is being tested?
- Leukocyte and Platelet Rich Fibrin plus Coronally Advanced Flap and Connective tissue graft plus Coronally Advanced Flap
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 34 participants
- Where
- 1 siteChile
- Study dates
- 1 Apr 2017to 15 Oct 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Systemically healthy patients
- Older than18 years
- At least one localized Miller class I or II gingival recession higher than 3mm at buccal aspect of anterior/premolar area
- An identifiable cement-enamel junction (CEJ)
- Without bleeding on probing (BOP)
- Pulp vitality
Who cannot join
- Smokers
- Pregnancy
- Active periodontal disease
- Previous periodontal surgical procedures in the recession area
- Coagulation disorders
- Anticoagulant treatment
- Patients who cannot comply the study and/or maintenance visits.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Leucocytes - and Platelet Rich Fibrin Versus Connective Tissue Graft Associated to Coronally Advanced Flap in the Treatment of Miller Class I and II Localized Gingival Recession: A Randomized Controlled Clinical Trial
Background: Nowadays, the use of connective tissue graft associated to the coronally advanced flap is considered the "gold standard" for localized gingival recession treatment. However, this technique requires a donor site, which can be associated with greater morbidity. The use of platelet concentrates, particularly the Leukocytes- and Platelets Rich Fibrin (L-PRF), it has emerged as an alternative for gingival recession treatment, due to its properties which enhance the regenerative process. Therefore, the purpose of this study was to evaluate and to compare the effect obtained with L-PRF versus connective tissue graft (CTG) associated to the Coronally Advanced Flap (CAF) in the treatment of Miller class I or II localized gingival recessions.
Methods: A randomized controlled clinical trial of parallel groups (1:1) with 17 recessions in each group was performed. Control group (CAF + CTG) and test group (CAF + L-PRF). In each group the following variable were measured: postoperative pain and incidence of post-surgical complications at 24-48-72 hours, gingival recession depth (RD), gingival recession width (RW), gingival thickness (GT), probing depth (PD), clinical insertion level (NIC), keratinized tissue height (KTH) before treatment and after 1, 3 and 6 months of root covering surgery and the root coverage esthetic score (RES) at 6 months after treatment.
Read the detailed description
Study design and participants A randomized controlled clinical trial of parallel groups (1:1) with 17 recessions in each group was performed. Control group (CAF + CTG) and test group (CAF + L-PRF). This study was approved by the ethical committee of Universidad de Los Andes, Santiago Chile (CEC201627) and in full accordance with the ethical principles of the Declaration of Helsinki, as revisited in 2000. The patients were instructed about the benefits and risks of the study and each participant signed an informed consent form.
Thirteen patients (9 females and 4 males; aged 26 to 53 years; mean year: 41,74; SD: 9,11 years) with a total of 34 gingival recession (27 in females and 7 in males) participated in the present study. (Figure 1)
The sample size was based on the detection of 1 mm difference in gingival recession reduction between the treatment groups (standard deviation 0.93), with a two-sided 5% significance level, a power of 85%.(36) The sample size calculation was obtained using the software STATA v14.0.
Initial therapy and clinical measurements The patient enrolled received a prophylaxis session (scaling and professional tooth cleaning), all patients had less of 20% of plaque or 80% oral hygiene according to the O´Leary oral hygiene index.(37) All clinical parameters measurements were performed by a single trained and calibrated examiner (C.A.) and masked for the treatment assigned. An Individual acrylic stents were prepared for all patients to take measurements of the constant points.
The following parameters were evaluated at baseline and 1, 3, and 6 months after treatment: 1) gingival recession depth (RD), distance between CEJ and gingival margin (GM); 2) gingival recession wide (RW), measured at CEJ level; 3) probing depth (PD), measured from margin of the gingiva to the gingival sulcus base; 4) clinical attachment level (CAL), measured from the CEJ to the gingival sulcus base; 5) keratinized tissue height (KTH), measured from the mucogingival junction to the gingival margin; 6) gingival thickness (GT) at 3 mm from the gingival margin, measured un local anesthesia with an endodontic spacer Nº 25 with its stopper silicone disc and an endodontic rule; 7) root coverage (RC) was calculated in millimeters and percentages according to the following formula: [(pre-operative RD - post-operative RD)/pre-operative RD] × 100.
PD, CAL, and KTH measurements were performed at the mid-buccal aspect of the teeth, by a manual probe and were rounded up to the nearest millimeter.(7)
Patient Evaluation of Postoperative Morbidity and Esthetics Pain score using a 100-mm visual analogue scale (VAS) (0 indicating no pain, 50 indicating average, and 100 indicating an unbearable pain) and the incidence of complications post-surgery (such as hematoma, swelling, bleeding, infection, wound dehiscence, etc.) responding dichotomous questions, were registered at 24, 48 and 72 hours after the surgery.
The root coverage esthetic score (RES) was evaluated at 6 months according to the protocol of Cairo et al.(38).
Surgical treatment Prior to starting the surgery, the surgeon opened the envelope labeled with the assigned treatment. All surgeries were performed by a single expert periodontist (A.S.). Under local anesthesia, the root area corresponding to buccal attachment loss (gingival recession + buccal PD) was instrumented with Gracey curettes until obtain a polished surface. Then, the surface was washed with a saline solution for 30 seconds. Additionally, a chemical treatment of the root surface for 3 minutes was done using Tetracycline HCl (250 mg/ml), mixing 250 mg in 1 ml of sterile water. After that, the root surface was rinsed for 60 seconds with saline solution.
The CAF was made following the protocol described by Zucchelli et al. in 2007. (39). Two horizontal beveled incision were done at mesial and distal of the gingival recession (each one 3 mm in length) at a distance from the tip of the anatomical papillae equal to the depth of the recession plus 1 mm. Both incisions were connected with an intrasulcular incision. From the horizontal incisions, two beveled obliques, slightly divergent, incisions were extended until the alveolar mucosa. Then, the trapezoidal-shaped flap, split-full-split from coronal to apical was elevated and the papillae (mesial and distal) were deepithelialized. When the margin of the flap was able to passively extend until more coronal of the CEJ the coronal mobilization of the flap was considered satisfactory.
According to the treatment assignment (control or test group), a connective tissue graft or a double L-PRF membrane was positioned at the level of CEJ, getting the stabilization with 5-0 resorbable suture. After that, the flap was coronally advanced and stabilized with interrupted sutures (5-0 resorbable) anchored to incisal contact points (mesial and distal) created with a flowable, light-curing resin material in the treated tooth. Finally, a gentle pression over the area with a moistened gauze with saline solution was performed.
L-PRF preparation 2 vacutainer tubes of 10 ml without anticoagulant of blood were obtained and centrifuged at 408 g for 12 minutes using a table centrifuge (IntraSpinTM, Intralock, Florida, USA) according to the protocol described by Temmerman et al. in 2016.(40) The L-PRF clots obtained were removed from the tube, separated of the red cells and located inside of Xpression box (IntraSpinTM, Intralock, Florida, USA) to convert them into membranes.
The two L-PRF membranes obtained were attached using a resorbable suture until obtain only one thicker and stable membrane. (Figure 2)
Postsurgical indications and control pain Ketoprofen 100 mg was administrated immediately before the surgery. Then, they took the same prescription every 12 hours for the next 2 days. In some specific cases, the prescription was extended to control pain and the extra doses was registered.
The patients received written and oral instructions about not touch the involved area, only liquid diet and do not make any hard effort or sports activity during two weeks until the sutures were removed. Related to oral hygiene after surgery, the patients were also instructed to not brush their treated teeth, just rinse with Chlorhexidine solution (0.12%) three times a day for 1 min. After suture removal, the chlorhexidine rinsing was maintained for additional 2 weeks. After that, the patients were again instructed with a -traumatic tooth brushing technique.
Randomization, Allocation Concealment, and Calibration Computer-Generated randomization was used to assign the patients with an allocation ratio of 1:1 into two study groups: CAF + L-PRF (17 gingival recession; control) and CAF + CTG (17 gingival recession; test). To conceal the treatment assignment, opaque envelopes containing the name of the intervention were used. During the intra-examiner calibration period, a 90% level of calibration (K coefficient = 0.90) was detected after triplicate measurement of gingival recession depth (GRD), distance from the CEJ to the margin of the gingiva, in 50 recession defects.
Statistical analysis Descriptive analysis was expressed as mean and standard deviation (SD) or median and interquartile range (IQR) according to distribution of data (normality) determinate by Shapiro-Wilk test. Student's t-test was used to evaluate differences between baseline measures and different evaluations times of variables expresses as mean, in the variables expresses as median was used the Wilcoxon test was applied. Categorical measurement was analyzed by Chi-square test. A p-value < 0.05 considered as significant in all tests. The analysis was performed with Stata software v.12, Stata Corp, College Station, TX.
- Conditions
- Gingival Recession, Localized
- Being tested
- Leukocyte and Platelet Rich Fibrin plus Coronally Advanced Flap, Connective tissue graft plus Coronally Advanced Flap
- Keywords
- Leukocyte and Platelet Rich Fibrin, Connective tissue graft, Gingival recession
- Medical subject headings
- Gingival Recession
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Leukocyte and Platelet Rich Fibrin plus Coronally Advanced FlapProcedure or surgery
Also called L-PRF + CAF
The Coronally advanced flap was made following the protocol described by Zucchelli et al. in 2007. (39). When the margin of the flap was able to passively extend until more coronal of the CEJ the coronal mobilization of the flap was considered satisfactory. A double L-PRF membrane was positioned at the level of CEJ, getting the stabilization with 5-0 resorbable suture. After that, the flap was coronally advanced and stabilized with interrupted sutures (5-0 resorbable) anchored to incisal contact points (mesial and distal) created with a flowable, light-curing resin material in the treated tooth. Finally, gentle pressure over the area with a moistened gauze with saline solution was performed.
Connective tissue graft plus Coronally Advanced FlapProcedure or surgery
Also called CTG + CAF
The Coronally advanced flap was made following the protocol described by Zucchelli et al. in 2007. (39). When the margin of the flap was able to passively extend until more coronal of the CEJ the coronal mobilization of the flap was considered satisfactory. Then connective tissue graft obtained from the palate was positioned at the level of CEJ, getting the stabilization with 5-0 resorbable suture. After that, the flap was coronally advanced and stabilized with interrupted sutures (5-0 resorbable) anchored to incisal contact points (mesial and distal) created with a flowable, light-curing resin material in the treated tooth. Finally, gentle pressure over the area with a moistened gauze with saline solution was performed.
| Study group | Role | What they receive |
|---|---|---|
| L-PRF+CAF | Active comparator | Leukocyte and Platelet Rich Fibrin plus Coronally Advanced Flap Receives: Procedure: Leukocyte and Platelet Rich Fibrin plus Coronally Advanced Flap |
| CTG+CAF | Active comparator | Connective Tissue graft plus Coronally Advanced Flap Receives: Procedure: Connective tissue graft plus Coronally Advanced Flap |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Recession depth (RD)
pre-operative RD - post-operative RD in millimeters
Measured: At 1 month, 3 months and 6 months
Secondary outcomes (9)
Change in Recession wide (RW)
pre-operative RW - post-operative RW in millimeters
Measured: At 1 month, 3 months and 6 months
Change in Percentage of root coverage
[(pre-operative RD - post-operative RD)/pre-operative RD] × 100 = (%)
Measured: At 1 month, 3 months and 6 months
Change in Gingival thickness (GT)
pre-operative GT - post-operative GT in millimeters
Measured: At 1 month, 3 months and 6 months
Change in Probing depth (PD)
pre-operative PD - post-operative PD in millimeters
Measured: At 1 month, 3 months and 6 months
Change in Clinical attachment level (CAL)
pre-operative CAL - post-operative CAL in millimeters
Measured: At 1 month, 3 months and 6 months
Change in Keratinized tissue height (KTH)
pre-operative KTH - post-operative KTH in millimeters
Measured: At 1 month, 3 months and 6 months
Post- operative pain
Mean of Visual Analogue Scale score . Outcomes from: no pain (0 mm) until severe pain (maximum 100 mm).
Measured: At 24, 48 and 72 hours after surgery.
Root Coverage Esthetic Score (RES)
Mean of Root Coverage Esthetic Score. Outcomes: from 0 (worse outcome) until 10 (better outcome)
Measured: At 6 months
Post-surgery complications incidence
Frequency and percentage of post-surgery complications
Measured: At 24, 48, 72 hours.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Nov 2019
- Study start1 Apr 2017
- Primary completion15 Oct 2019
- Study completion15 Oct 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Gingival Recession, LocalizedStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Randomized controlled clinical trial of parallel group (1:1)
- Masking
- Double blind
- Who is masked
- Investigator, Outcomes assessor
- Enrolment
- 34 participants (actual)
Sponsor and investigators
- Lead sponsor
- Universidad de los Andes, Chile
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Catherine Andrade, Universidad de los Andes, Chile
- Investigators
- Catherine Andrade, Principal investigator, Universidad de los Andes, Chile
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04165044
- Sponsor's protocol ID
- L-PRF in gingival recession
- Status last verified
- Nov 2019
- First submitted
- 7 Nov 2019
- Last updated
- 15 Nov 2019
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 15 Nov 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Leucocytes - and Platelet Rich Fibrin Versus Connective Tissue Graft Associated to Coronally Advanced Flap in the Treatment of Miller Class I and II Localized Gingival Recession: A Randomized Controlled Clinical Trial
- ClinicalTrials.gov ID
- NCT04165044
- Acronym / sponsor ID
- L-PRF in gingival recession
- Conditions
- Gingival Recession, Localized
- Keywords
- Leukocyte and Platelet Rich Fibrin, Connective tissue graft, Gingival recession
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 34 participants (actual)
- Lead sponsor
- Universidad de los Andes, ChileUniversity, hospital or other
- Study start
- 1 Apr 2017 (actual)
- Primary completion
- 15 Oct 2019 (actual)
- Study completion
- 15 Oct 2019 (actual)
- First posted
- 15 Nov 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Background: Nowadays, the use of connective tissue graft associated to the coronally advanced flap is considered the "gold standard" for localized gingival recession treatment. However, this technique requires a donor site, which can be associated with greater morbidity. The use of platelet concentrates, particularly the Leukocytes- and Platelets Rich Fibrin (L-PRF), it has emerged as an alternative for gingival recession treatment, due to its properties which enhance the regenerative process. Therefore, the purpose of this study was to evaluate and to compare the effect obtained with L-PRF versus connective tissue graft (CTG) associated to the Coronally Advanced Flap (CAF) in the treatment of Miller class I or II localized gingival recessions.
Methods: A randomized controlled clinical trial of parallel groups (1:1) with 17 recessions in each group was performed. Control group (CAF + CTG) and test group (CAF + L-PRF). In each group the following variable were measured: postoperative pain and incidence of post-surgical complications at 24-48-72 hours, gingival recession depth (RD), gingival recession width (RW), gingival thickness (GT), probing depth (PD), clinical insertion level (NIC), keratinized tissue height (KTH) before treatment and after 1, 3 and 6 months of root covering surgery and the root coverage esthetic score (RES) at 6 months after treatment.
Detailed description
Study design and participants A randomized controlled clinical trial of parallel groups (1:1) with 17 recessions in each group was performed. Control group (CAF + CTG) and test group (CAF + L-PRF). This study was approved by the ethical committee of Universidad de Los Andes, Santiago Chile (CEC201627) and in full accordance with the ethical principles of the Declaration of Helsinki, as revisited in 2000. The patients were instructed about the benefits and risks of the study and each participant signed an informed consent form.
Thirteen patients (9 females and 4 males; aged 26 to 53 years; mean year: 41,74; SD: 9,11 years) with a total of 34 gingival recession (27 in females and 7 in males) participated in the present study. (Figure 1)
The sample size was based on the detection of 1 mm difference in gingival recession reduction between the treatment groups (standard deviation 0.93), with a two-sided 5% significance level, a power of 85%.(36) The sample size calculation was obtained using the software STATA v14.0.
Initial therapy and clinical measurements The patient enrolled received a prophylaxis session (scaling and professional tooth cleaning), all patients had less of 20% of plaque or 80% oral hygiene according to the O´Leary oral hygiene index.(37) All clinical parameters measurements were performed by a single trained and calibrated examiner (C.A.) and masked for the treatment assigned. An Individual acrylic stents were prepared for all patients to take measurements of the constant points.
The following parameters were evaluated at baseline and 1, 3, and 6 months after treatment: 1) gingival recession depth (RD), distance between CEJ and gingival margin (GM); 2) gingival recession wide (RW), measured at CEJ level; 3) probing depth (PD), measured from margin of the gingiva to the gingival sulcus base; 4) clinical attachment level (CAL), measured from the CEJ to the gingival sulcus base; 5) keratinized tissue height (KTH), measured from the mucogingival junction to the gingival margin; 6) gingival thickness (GT) at 3 mm from the gingival margin, measured un local anesthesia with an endodontic spacer Nº 25 with its stopper silicone disc and an endodontic rule; 7) root coverage (RC) was calculated in millimeters and percentages according to the following formula: [(pre-operative RD - post-operative RD)/pre-operative RD] × 100.
PD, CAL, and KTH measurements were performed at the mid-buccal aspect of the teeth, by a manual probe and were rounded up to the nearest millimeter.(7)
Patient Evaluation of Postoperative Morbidity and Esthetics Pain score using a 100-mm visual analogue scale (VAS) (0 indicating no pain, 50 indicating average, and 100 indicating an unbearable pain) and the incidence of complications post-surgery (such as hematoma, swelling, bleeding, infection, wound dehiscence, etc.) responding dichotomous questions, were registered at 24, 48 and 72 hours after the surgery.
The root coverage esthetic score (RES) was evaluated at 6 months according to the protocol of Cairo et al.(38).
Surgical treatment Prior to starting the surgery, the surgeon opened the envelope labeled with the assigned treatment. All surgeries were performed by a single expert periodontist (A.S.). Under local anesthesia, the root area corresponding to buccal attachment loss (gingival recession + buccal PD) was instrumented with Gracey curettes until obtain a polished surface. Then, the surface was washed with a saline solution for 30 seconds. Additionally, a chemical treatment of the root surface for 3 minutes was done using Tetracycline HCl (250 mg/ml), mixing 250 mg in 1 ml of sterile water. After that, the root surface was rinsed for 60 seconds with saline solution.
The CAF was made following the protocol described by Zucchelli et al. in 2007. (39). Two horizontal beveled incision were done at mesial and distal of the gingival recession (each one 3 mm in length) at a distance from the tip of the anatomical papillae equal to the depth of the recession plus 1 mm. Both incisions were connected with an intrasulcular incision. From the horizontal incisions, two beveled obliques, slightly divergent, incisions were extended until the alveolar mucosa. Then, the trapezoidal-shaped flap, split-full-split from coronal to apical was elevated and the papillae (mesial and distal) were deepithelialized. When the margin of the flap was able to passively extend until more coronal of the CEJ the coronal mobilization of the flap was considered satisfactory.
According to the treatment assignment (control or test group), a connective tissue graft or a double L-PRF membrane was positioned at the level of CEJ, getting the stabilization with 5-0 resorbable suture. After that, the flap was coronally advanced and stabilized with interrupted sutures (5-0 resorbable) anchored to incisal contact points (mesial and distal) created with a flowable, light-curing resin material in the treated tooth. Finally, a gentle pression over the area with a moistened gauze with saline solution was performed.
L-PRF preparation 2 vacutainer tubes of 10 ml without anticoagulant of blood were obtained and centrifuged at 408 g for 12 minutes using a table centrifuge (IntraSpinTM, Intralock, Florida, USA) according to the protocol described by Temmerman et al. in 2016.(40) The L-PRF clots obtained were removed from the tube, separated of the red cells and located inside of Xpression box (IntraSpinTM, Intralock, Florida, USA) to convert them into membranes.
The two L-PRF membranes obtained were attached using a resorbable suture until obtain only one thicker and stable membrane. (Figure 2)
Postsurgical indications and control pain Ketoprofen 100 mg was administrated immediately before the surgery. Then, they took the same prescription every 12 hours for the next 2 days. In some specific cases, the prescription was extended to control pain and the extra doses was registered.
The patients received written and oral instructions about not touch the involved area, only liquid diet and do not make any hard effort or sports activity during two weeks until the sutures were removed. Related to oral hygiene after surgery, the patients were also instructed to not brush their treated teeth, just rinse with Chlorhexidine solution (0.12%) three times a day for 1 min. After suture removal, the chlorhexidine rinsing was maintained for additional 2 weeks. After that, the patients were again instructed with a -traumatic tooth brushing technique.
Randomization, Allocation Concealment, and Calibration Computer-Generated randomization was used to assign the patients with an allocation ratio of 1:1 into two study groups: CAF + L-PRF (17 gingival recession; control) and CAF + CTG (17 gingival recession; test). To conceal the treatment assignment, opaque envelopes containing the name of the intervention were used. During the intra-examiner calibration period, a 90% level of calibration (K coefficient = 0.90) was detected after triplicate measurement of gingival recession depth (GRD), distance from the CEJ to the margin of the gingiva, in 50 recession defects.
Statistical analysis Descriptive analysis was expressed as mean and standard deviation (SD) or median and interquartile range (IQR) according to distribution of data (normality) determinate by Shapiro-Wilk test. Student's t-test was used to evaluate differences between baseline measures and different evaluations times of variables expresses as mean, in the variables expresses as median was used the Wilcoxon test was applied. Categorical measurement was analyzed by Chi-square test. A p-value < 0.05 considered as significant in all tests. The analysis was performed with Stata software v.12, Stata Corp, College Station, TX.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (investigator, outcomes assessor)
- Number of arms
- 2
- Model description
- Randomized controlled clinical trial of parallel group (1:1)
| Arm | Type | Receives |
|---|---|---|
| L-PRF+CAF | Active comparator | Procedure: Leukocyte and Platelet Rich Fibrin plus Coronally Advanced FlapLeukocyte and Platelet Rich Fibrin plus Coronally Advanced Flap |
| CTG+CAF | Active comparator | Procedure: Connective tissue graft plus Coronally Advanced FlapConnective Tissue graft plus Coronally Advanced Flap |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Systemically healthy patients
- Older than18 years
- At least one localized Miller class I or II gingival recession higher than 3mm at buccal aspect of anterior/premolar area
- An identifiable cement-enamel junction (CEJ)
- Without bleeding on probing (BOP)
Key exclusion criteria (7 listed)
- Smokers
- Pregnancy
- Active periodontal disease
- Previous periodontal surgical procedures in the recession area
- Coagulation disorders
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Leukocyte and Platelet Rich Fibrin plus Coronally Advanced FlapAlso: L-PRF + CAFThe Coronally advanced flap was made following the protocol described by Zucchelli et al. in 2007. (39). When the margin of the flap was able to passively extend until more coronal of the CEJ the coronal mobilization of the flap was considered satisfactory. A double L-PRF membrane was positioned at the level of CEJ, getting the stabilization with 5-0 resorbable suture. After that, the flap was coronally advanced and stabilized with interrupted sutures (5-0 resorbable) anchored to incisal contact points (mesial and distal) created with a flowable, light-curing resin material in the treated tooth. Finally, gentle pressure over the area with a moistened gauze with saline solution was performed. | Procedure or surgery | L-PRF+CAF |
| Connective tissue graft plus Coronally Advanced FlapAlso: CTG + CAFThe Coronally advanced flap was made following the protocol described by Zucchelli et al. in 2007. (39). When the margin of the flap was able to passively extend until more coronal of the CEJ the coronal mobilization of the flap was considered satisfactory. Then connective tissue graft obtained from the palate was positioned at the level of CEJ, getting the stabilization with 5-0 resorbable suture. After that, the flap was coronally advanced and stabilized with interrupted sutures (5-0 resorbable) anchored to incisal contact points (mesial and distal) created with a flowable, light-curing resin material in the treated tooth. Finally, gentle pressure over the area with a moistened gauze with saline solution was performed. | Procedure or surgery | CTG+CAF |
Primary outcome
Change in Recession depth (RD)
Time frame: At 1 month, 3 months and 6 months
pre-operative RD - post-operative RD in millimeters
9 secondary outcomes
Change in Recession wide (RW)
Time frame: At 1 month, 3 months and 6 months
Change in Percentage of root coverage
Time frame: At 1 month, 3 months and 6 months
Change in Gingival thickness (GT)
Time frame: At 1 month, 3 months and 6 months
Change in Probing depth (PD)
Time frame: At 1 month, 3 months and 6 months
Change in Clinical attachment level (CAL)
Time frame: At 1 month, 3 months and 6 months
Change in Keratinized tissue height (KTH)
Time frame: At 1 month, 3 months and 6 months
Post- operative pain
Time frame: At 24, 48 and 72 hours after surgery.
Root Coverage Esthetic Score (RES)
Time frame: At 6 months
Post-surgery complications incidence
Time frame: At 24, 48, 72 hours.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Nov 2019.
Related trials for Gingival Recession, Localized
Not yet recruiting
Free Soft Tissue Grafts (FSTG) Using Autograft Palatal Donor Tissue vs. Xenograft Collagen Matrix (Zderm™)
Gingival Recession Localized Moderate, Dental Implant
Recruiting
Palatal Wound Healing After Free Gingival Graft Harvest in Diabetic Patients: A Clinical Trial
Diabetes Mellitus, Gingival Recession, Generalized
Not yet recruiting
Evaluation of the Effect of Smoking on Palatal Donor Site Tissue Profile in the Success of Connective Tissue Grafts
Soft Tissue Augmentation, Gingival Recession Localized Moderate
Not yet recruiting
Oral Mucosa Wound Healing After Gingival Recession Treatment in Diabetic Patients. A Clinical Study.
Diabetes Mellitus, Gingival Recession, Generalized
Not yet recruiting
Clinical and Histological Evaluation of Subepithelial Connective Tissue Graft Maturation at Different Healing Timepoints, With and Without Topical Application of a Polynucleotide- and Hyaluronic Acid-Based Gel
Gingival Recession, Generalized, Gingival Recession, Localized
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Catherine Andrade principal investigator
Universidad de los Andes, Chile
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Leukocyte and Platelet Rich Fibrin plus Coronally Advanced Flap and Connective tissue graft plus Coronally Advanced Flap in people with Gingival Recession, Localized, run by Universidad de los Andes, Chile at 1 site in Chile.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Nov 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Chile. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Recession depth (RD) (time frame: At 1 month, 3 months and 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Nov 2019.